Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skippingPeter Gee(Kyoto University), Akitsu Hotta(Kyoto University)Nature CommunicationsMarch 13, 202010.1038/s41467-020-14957-yCited by 359SaveCiteExport RISWatch citationsRelated PapersLow immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice|Nature Communications|2021|277Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein|Stem Cell Reports|2021|51